Literature DB >> 12145766

Use of bone biochemical markers with dual-energy x-ray absorptiometry for early determination of bone loss in persons with spinal cord injury.

Laurent Maïmoun1, Isabelle Couret, Jean-Paul Micallef, Edouard Peruchon, Denis Mariano-Goulart, Michel Rossi, Jean-Louis Leroux, Freddy Ohanna.   

Abstract

Our cross-sectional study aimed at the early determination of changes in bone metabolism in terms of bone mineral density (BMD) and bone turnover in persons with complete spinal cord injury (SCI) during the acute phase of paraplegia. Combined dual-energy x-ray absorptiometry (DXA) and specific biochemical markers of bone turnover were used to determine bone metabolism. Seven persons with SCI (age, 31.3 +/- 9.5 years) who had sustained injury an average of 3 months earlier (103 +/- 10.8 days) were compared with 10 able-bodied controls (27.5 +/- 4.3 years). Four paraplegics and 3 quadriplegics composed the SCI group. BMD was measured by DXA, while bone turnover was evaluated by serum osteocalcin (OC), bone alkaline phosphatase (B-ALP), and serum and urinary type I collagen C-telopeptide (CTXs and CTXu). Regional BMD (proximal femur, lumbar spine, radius, lower limb) was similar in the 2 groups except in the upper limb (P <.05). CTXs and CTXu were significantly higher in SCI (P <.01 and P <.001, respectively), whereas among the bone formation markers used, only serum OC was affected by immobilization (P <.05). The SCI group developed hypercalciuria (0.76 +/- 0.37 v 0.35 +/- 0.14), whereas calcemia was normal (2.42 +/- 0.09 v 2.31 +/- 0.10). Intact parathyroid hormone (iPTH) and 1.25 (OH)(2) vitamin D levels were suppressed in persons with SCI (P <.001) by 80.6% and 66%, respectively. In conclusion, it was not possible to detect any variation in BMD from the DXA technique at this early stage of demineralization, but the sensitivity and early response of the biochemical markers strongly suggested their usefulness for the early identification of persons with SCI at risk of severe osteoporosis. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145766     DOI: 10.1053/meta.2002.34013

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  29 in total

1.  Effect of a convenient single 90-mg pamidronate dose on biochemical markers of bone metabolism in patients with acute spinal cord injury.

Authors:  Jeffrey I Mechanick; Kan Liu; David M Nierman; Adam Stein
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

Review 2.  Bone loss and muscle atrophy in spinal cord injury: epidemiology, fracture prediction, and rehabilitation strategies.

Authors:  Lora Giangregorio; Neil McCartney
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

3.  Spinal cord injury causes more damage to bone mass, bone structure, biomechanical properties and bone metabolism than sciatic neurectomy in young rats.

Authors:  S-D Jiang; L-S Jiang; L-Y Dai
Journal:  Osteoporos Int       Date:  2006-07-28       Impact factor: 4.507

4.  Adult rat bones maintain distinct regionalized expression of markers associated with their development.

Authors:  Simon C F Rawlinson; Ian J McKay; Mandeep Ghuman; Claudia Wellmann; Paul Ryan; Saengsome Prajaneh; Gul Zaman; Francis J Hughes; Virginia J Kingsmill
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

5.  Bone loss and impaired fracture healing in spinal cord injured mice.

Authors:  W-G Ding; S-D Jiang; Y-H Zhang; L-S Jiang; L-Y Dai
Journal:  Osteoporos Int       Date:  2010-05-06       Impact factor: 4.507

6.  Sclerostin: a candidate biomarker of SCI-induced osteoporosis.

Authors:  L R Morse; S Sudhakar; A A Lazzari; C Tun; E Garshick; R Zafonte; R A Battaglino
Journal:  Osteoporos Int       Date:  2012-07-17       Impact factor: 4.507

7.  Evaluation of bone mineral density in patients with spinal cord injury.

Authors:  Kurtulus Kaya; Canan Aybay; Sumru Ozel; Nilufer Kutay; Ordu Gokkaya
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

8.  Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury.

Authors:  J S Bubbear; A Gall; F R I Middleton; M Ferguson-Pell; R Swaminathan; R W Keen
Journal:  Osteoporos Int       Date:  2010-04-01       Impact factor: 4.507

9.  Effects of electromyostimulation on muscle and bone in men with acute traumatic spinal cord injury: A randomized clinical trial.

Authors:  Alfredo Arija-Blázquez; Silvia Ceruelo-Abajo; María S Díaz-Merino; Juan Antonio Godino-Durán; Luís Martínez-Dhier; José L R Martin; José Florensa-Vila
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

Review 10.  Bone and brain: a review of neural, hormonal, and musculoskeletal connections.

Authors:  Kevin B Jones; Anthony V Mollano; Jose A Morcuende; Reginald R Cooper; Charles L Saltzman
Journal:  Iowa Orthop J       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.